ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

June 19, 1992

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

ASCO to form commission to study tobacco problem.

January 23, 2004

In Brief: Brown Named Dean At Wisconsin, Carnone To Head Cancer Center With Rusch Retirement

June 30, 1978

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

February 1, 2008

BRAF Mutation Testing Classifies Indeterminate FNA Samples

March 29, 2013